| 1 |
Management of the Adverse Effects of Immune Checkpoint Inhibitors |
|
|
| Manuel Morgado,Ana Plácido,Sandra Morgado,Fátima Roque |
|
| Vaccines. 2020; 8(4): 575 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Recent advances in targeted nanomedicine as promising antitumor therapeutics |
|
|
| Siddhanth Hejmady,Rajesh Pradhan,Amit Alexander,Mukta Agrawal,Gautam Singhvi,Bapi Gorain,Sanjay Tiwari,Prashant Kesharwani,Sunil Kumar Dubey |
|
| Drug Discovery Today. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Durvalumab Immunotherapy: Nursing Management of Immune-Related Adverse Events During the Journey of Patients With Stage III Non-Small Cell Lung Cancer |
|
|
| Marianne Davies,Emily Duffield |
|
| Clinical Journal of Oncology Nursing. 2020; 24(3): 277 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
The Long Half-Life of Programmed Cell Death Protein 1 Inhibitors May Increase the Frequency of Immune-Related Adverse Events After Subsequent EGFR Tyrosine Kinase Inhibitor Therapy |
|
|
| Yuki Shinno,Yasushi Goto,Mayu Ohuchi,Akinobu Hamada,Hiroshi Nokihara,Yasuhiro Fujiwara,Yuichiro Ohe |
|
| JTO Clinical and Research Reports. 2020; 1(1): 100008 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Oncolytic viruses: what to expect from their use in cancer treatment |
|
|
| Maria Terrível,Catarina Gromicho,Ana Miguel Matos |
|
| Microbiology and Immunology. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Hybrid phenotype mining method for investigating off-target protein and underlying side effects of anti-tumor immunotherapy |
|
|
| Yuyu Zheng,Xiangyu Meng,Pierre Zweigenbaum,Lingling Chen,Jingbo Xia |
|
| BMC Medical Informatics and Decision Making. 2020; 20(S3) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Analysis of immune-related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report database |
|
|
| Shiori Hasegawa,Hiroaki Ikesue,Satoshi Nakao,Kazuyo Shimada,Ririka Mukai,Mizuki Tanaka,Kiyoka Matsumoto,Misaki Inoue,Riko Satake,Yu Yoshida,Fumiya Goto,Tohru Hashida,Mitsuhiro Nakamura |
|
| Pharmacoepidemiology and Drug Safety. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Health-related quality of life in cancer patients treated with immune checkpoint inhibitors: A systematic review on reporting of methods in randomized controlled trials |
|
|
| Stéphane Faury,Jérôme Foucaud,Ali Montazeri |
|
| PLOS ONE. 2020; 15(1): e0227344 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update |
|
|
| Meenu Mehta,Daljeet S. Dhanjal,Keshav R. Paudel,Bhupender Singh,Gaurav Gupta,S. Rajeshkumar,Lakshmi Thangavelu,Murtaza M. Tambuwala,Hamid A. Bakshi,Dinesh K. Chellappan,Parijat Pandey,Harish Dureja,Nitin B. Charbe,Sachin K. Singh,Shakti D. Shukla,Srinivas Nammi,Alaa A. Aljabali,Peter R. Wich,Philip M. Hansbro,Saurabh Satija,Kamal Dua |
|
| Inflammopharmacology. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Novel Small Molecule Inhibitors of Programmed Cell Death (PD)-1, and its Ligand, PD-L1 in Cancer Immunotherapy: A Review Update of Patent Literature |
|
|
| Spandana R. Kopalli,Tae-Bong Kang,Kwang-Ho Lee,Sushruta Koppula |
|
| Recent Patents on Anti-Cancer Drug Discovery. 2019; 14(2): 100 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Preclinical Evaluation and Clinical Translation of Magnetite-Based Nanomedicines |
|
|
| Julia Nuzhina,Alexander A. Shtil,Artur Prilepskii,Vladimir V. Vinogradov |
|
| Journal of Drug Delivery Science and Technology. 2019; : 101282 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Immunology and Immunotherapy in Critical Care: An Overview |
|
|
| Nancy Munro |
|
| AACN Advanced Critical Care. 2019; 30(2): 113 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
Mistletoe and Immunomodulation: Insights and Implications for Anticancer Therapies |
|
|
| Shiao Li Oei,Anja Thronicke,Friedemann Schad |
|
| Evidence-Based Complementary and Alternative Medicine. 2019; 2019: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs |
|
|
| Alyson Haslam,Vinay Prasad |
|
| JAMA Network Open. 2019; 2(5): e192535 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
Immunological consequences of chemotherapy: Single drugs, combination therapies and nanoparticle-based treatments |
|
|
| Anusha Pusuluri,Debra Wu,Samir Mitragotri |
|
| Journal of Controlled Release. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
Peptide-based targeted therapeutics and apoptosis imaging probes for cancer therapy |
|
|
| Sri Murugan Poongkavithai Vadevoo,Smriti Gurung,Fatima Khan,Md. Enamul Haque,Gowri Rangaswamy Gunassekaran,Lianhua Chi,Uttapol Permpoon,Byungheon Lee |
|
| Archives of Pharmacal Research. 2019; 42(2): 150 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 17 |
Surgical Tumor-Derived Personalized Photothermal Vaccine Formulation for Cancer Immunotherapy |
|
|
| Xinyu Ye,Xin Liang,Qian Chen,Qianwei Miao,Xiuli Chen,Xudong Zhang,Lin Mei |
|
| ACS Nano. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 18 |
Immunotherapy in non-small cell lung cancer: The past, the present, and the future |
|
|
| Meng Lu,Yanjun Su |
|
| Thoracic Cancer. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 19 |
Targeting the Interplay between Epithelial-to-Mesenchymal-Transition and the Immune System for Effective Immunotherapy |
|
|
| Rama Soundararajan,Jared Fradette,Jessica Konen,Stacy Moulder,Xiang Zhang,Don Gibbons,Navin Varadarajan,Ignacio Wistuba,Debasish Tripathy,Chantale Bernatchez,Lauren Byers,Jeffrey Chang,Alejandro Contreras,Bora Lim,Edwin Parra,Emily Roarty,Jing Wang,Fei Yang,Michelle Barton,Jeffrey Rosen,Sendurai Mani |
|
| Cancers. 2019; 11(5): 714 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 20 |
A Case Study Examining the Usefulness of Cure Modelling for the Prediction of Survival Based on Data Maturity |
|
|
| Tim S. Grant,Darren Burns,Christopher Kiff,Dawn Lee |
|
| PharmacoEconomics. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 21 |
A Case of Severe Seronegative Inflammatory Arthritis due to Nivolumab and Review of the Literature |
|
|
| Bicky Thapa,Asad Ali,Raunak Nair,Rishik Vashisht,Cassandra Calabrese |
|
| Case Reports in Rheumatology. 2019; 2019: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 22 |
Recruiting monomer for dimer formation: resolving the antagonistic mechanisms of novel immune check point inhibitors against Programmed Death Ligand-1 in cancer immunotherapy |
|
|
| Opeyemi S. Soremekun,Fisayo A. Olotu,Clement Agoni,Mahmoud E. S. Soliman |
|
| Molecular Simulation. 2019; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 23 |
Making cold malignant pleural effusions hot: driving novel immunotherapies |
|
|
| Pranav Murthy,Chigozirim N. Ekeke,Kira L. Russell,Samuel C. Butler,Yue Wang,James D. Luketich,Adam C. Soloff,Rajeev Dhupar,Michael T. Lotze |
|
| OncoImmunology. 2019; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 24 |
Immunotherapy: enhancing the efficacy of this promising therapeutic in multiple cancers |
|
|
| Jitwadee Inthagard,Joanne Edwards,Antonia K. Roseweir |
|
| Clinical Science. 2019; 133(2): 181 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 25 |
Immunotherapy: last bullet in platinum refractory germ cell testicular cancer |
|
|
| Albert Semaan,Fady GH Haddad,Roland Eid,Hampig Raphael Kourie,Elie Nemr |
|
| Future Oncology. 2019; 15(5): 533 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 26 |
Immunoepigenetics Combination Therapies: An Overview of the Role of HDACs in Cancer Immunotherapy |
|
|
| Debarati Banik,Sara Moufarrij,Alejandro Villagra |
|
| International Journal of Molecular Sciences. 2019; 20(9): 2241 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 27 |
Effectiveness of Multi-Prognostic Index in older patients with advanced malignancies treated with immunotherapy |
|
|
| Andrea Sbrana,Rachele Antognoli,Giuseppe Pasqualetti,Giuseppe Linsalata,Chukwma Okoye,Valeria Calsolaro,Federico Paolieri,Francesco Bloise,Sergio Ricci,Andrea Antonuzzo,Fabio Monzani |
|
| Journal of Geriatric Oncology. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 28 |
Kiss and Run: Promoting Effective and Targeted Cellular Uptake of a Drug Delivery Vehicle Composed of an Integrin-Targeting Diketopiperazine Peptidomimetic and a Cell-Penetrating Peptide |
|
|
| Lucia Feni,Sara Parente,Clémence Robert,Silvia Gazzola,Daniela Arosio,Umberto Piarulli,Ines Neundorf |
|
| Bioconjugate Chemistry. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 29 |
Nivolumab-induced immune-mediated neurotoxicity in Hodgkin lymphoma |
|
|
| James Lopez,Naveen Yarlagadda,Zaid Gheith,Meera Mohan,Appalanaidu Sasapu |
|
| Baylor University Medical Center Proceedings. 2019; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 30 |
Landscape of Germline Mutations in DNA Repair Genes for Breast Cancer in Latin America: Opportunities for PARP-Like Inhibitors and Immunotherapy |
|
|
| Arash Urbina-Jara,Arash Rojas-Martinez,Arash Martinez-Ledesma,Arash Aguilar,Arash Villarreal-Garza,Arash Ortiz-Lopez |
|
| Genes. 2019; 10(10): 786 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 31 |
What can independent research for mesothelioma achieve to treat this orphan disease? |
|
|
| Alice Guazzelli,Parisa Meysami,Emyr Bakker,Ezio Bonanni,Constantinos Demonacos,Marija Krstic-Demonacos,Luciano Mutti |
|
| Expert Opinion on Investigational Drugs. 2019; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 32 |
Atezolizumab-Induced Autoimmune Diabetes in a Patient With Metastatic Lung Cancer |
|
|
| Jin Sothornwit,Anakapong Phunmanee,Chatlert Pongchaiyakul |
|
| Frontiers in Endocrinology. 2019; 10 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 33 |
Tn antigen analogues: the synthetic way to “upgrade” an attracting tumour associated carbohydrate antigen (TACA) |
|
|
| Cristina Nativi,Francesco Papi,Stefano Roelens |
|
| Chemical Communications. 2019; 55(54): 7729 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 34 |
Iatrogenic CNS demyelination in the era of modern biologics |
|
|
| Neha Kumar,Hesham Abboud |
|
| Multiple Sclerosis Journal. 2019; 25(8): 1079 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 35 |
A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity |
|
|
| Prabhakaran Kumar,Palash Bhattacharya,Bellur S. Prabhakar |
|
| Journal of Autoimmunity. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 36 |
Addressing New Diagnostic and Treatment Challenges Associated With a New Age of Cancer Treatment |
|
|
| Jason J. Bischof,Carolyn J. Presley,Jeffrey M. Caterino |
|
| Annals of Emergency Medicine. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 37 |
Immunotherapy Adverse Events, Part 2: The Role of the Primary Care Nurse Practitioner |
|
|
| Fedricker D. Barber |
|
| The Journal for Nurse Practitioners. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 38 |
Guillain-Barré-like syndrome during pembrolizumab treatment |
|
|
| Stephanie Ong,James Chapman,Gavin Young,Talal Mansy |
|
| Muscle & Nerve. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 39 |
Data-Driven Methods for Advancing Precision Oncology |
|
|
| Prema Nedungadi,Akshay Iyer,Georg Gutjahr,Jasmine Bhaskar,Asha B. Pillai |
|
| Current Pharmacology Reports. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 40 |
Characterization of cancer genomic heterogeneity by next-generation sequencing advances precision medicine in cancer treatment |
|
|
| Jialing Zhang,Stephan Stanislaw Späth,Sadie L Marjani,Wengeng Zhang,Xinghua Pan |
|
| Precision Clinical Medicine. 2018; 1(1): 29 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 41 |
Next generation of immune checkpoint therapy in cancer: new developments and challenges |
|
|
| Julian A. Marin-Acevedo,Bhagirathbhai Dholaria,Aixa E. Soyano,Keith L. Knutson,Saranya Chumsri,Yanyan Lou |
|
| Journal of Hematology & Oncology. 2018; 11(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 42 |
Ex Vivo Tumor-on-a-Chip Platforms to Study Intercellular Interactions within the Tumor Microenvironment |
|
|
| Vardhman Kumar,Shyni Varghese |
|
| Advanced Healthcare Materials. 2018; : 1801198 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 43 |
A review and validation of overall survival extrapolation in health technology assessments of cancer immunotherapy by the National Institute for Health and Care Excellence: how did the initial best estimate compare to trial data subsequently made available? |
|
|
| Ash Bullement,Yang Meng,Miranda Cooper,Dawn Lee,Tara Louise Harding,Chris O’Regan,Raquel Aguiar-Ibanez |
|
| Journal of Medical Economics. 2018; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 44 |
Oncolytic adenovirus: A tool for cancer therapy in combination with other therapeutic approaches |
|
|
| Nasser Hashemi Goradel,Nasir Mohajel,Ziba Veisi Malekshahi,Samira Jahangiri,Masoud Najafi,Bagher Farhood,Keywan Mortezaee,Babak Negahdari,Arash Arashkia |
|
| Journal of Cellular Physiology. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 45 |
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline |
|
|
| Julie R. Brahmer,Christina Lacchetti,Bryan J. Schneider,Michael B. Atkins,Kelly J. Brassil,Jeffrey M. Caterino,Ian Chau,Marc S. Ernstoff,Jennifer M. Gardner,Pamela Ginex,Sigrun Hallmeyer,Jennifer Holter Chakrabarty,Natasha B. Leighl,Jennifer S. Mammen,David F. McDermott,Aung Naing,Loretta J. Nastoupil,Tanyanika Phillips,Laura D. Porter,Igor Puzanov,Cristina A. Reichner,Bianca D. Santomasso,Carole Seigel,Alexander Spira,Maria E. Suarez-Almazor,Yinghong Wang,Jeffrey S. Weber,Jedd D. Wolchok,John A. Thompson |
|
| Journal of Clinical Oncology. 2018; 36(17): 1714 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 46 |
Development of mRNA vaccines and their prophylactic and therapeutic applications |
|
|
| Kyuri Lee,Minjeong Kim,Yunmi Seo,Hyukjin Lee |
|
| Nano Research. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 47 |
Checkpoint inhibitors: What gastroenterologists need to know |
|
|
| Monjur Ahmed |
|
| World Journal of Gastroenterology. 2018; 24(48): 5433 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 48 |
Analysis of Vipadenant and Its In Vitro and In Vivo Metabolites via Liquid Chromatography-Quadrupole-Time-of-Flight Mass Spectrometry |
|
|
| Seok-Ho Shin,Min-Ho Park,Jin-Ju Byeon,Byeong Lee,Yuri Park,Nahye Kim,Jangmi Choi,Young Shin |
|
| Pharmaceutics. 2018; 10(4): 260 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 49 |
Survival Extrapolation in Cancer Immunotherapy: A Validation-Based Case Study |
|
|
| Ash Bullement,Nicholas R. Latimer,Helen Bell Gorrod |
|
| Value in Health. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 50 |
Diagnostik und Therapie von immunvermittelten Nebenwirkungen durch Checkpointinhibitoren in der Intensivmedizin |
|
|
| Y. d’Hargues,J. Prinz,P. Gödel,A. Shimabukuro-Vornhagen,M. Kochanek,B. Böll |
|
| Medizinische Klinik - Intensivmedizin und Notfallmedizin. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 51 |
Therapeutic vaccines for high-risk HPV-associated diseases |
|
|
| Aleyo Chabeda,Romana J.R. Yanez,Renate Lamprecht,Ann E. Meyers,Edward P. Rybicki,Inga I. Hitzeroth |
|
| Papillomavirus Research. 2018; 5: 46 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 52 |
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Summary |
|
|
| Julie R. Brahmer,Christina Lacchetti,John A. Thompson |
|
| Journal of Oncology Practice. 2018; 14(4): 247 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 53 |
Nano-pulse stimulation induces potent immune responses, eradicating local breast cancer while reducing distant metastases |
|
|
| Siqi Guo,Yu Jing,Niculina I. Burcus,Brittany P. Lassiter,Royena Tanaz,Richard Heller,Stephen J. Beebe |
|
| International Journal of Cancer. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
